Psoriatic arthritis: clinical observation
https://doi.org/10.25789/YMJ.2020.70.32
Abstract
The article presents clinical observation of a family case of psoriasis complicated with a psoriatic arthritis. The described case sets up physicians' alertness with respect to psoriatic arthritis in differential diagnostics with such specific diseases as rheumatoid arthritis, gout. Active detection of patients with psoriatic arthritis requires first of all correct interpretation of anamnesis, clinical, laboratory and radiological data.
About the Authors
K. E. PopovaRussian Federation
Popova Kristina Evgenyevna – physician-therapist
T. E. Popova
Russian Federation
Popova Tatiana Egorovna – MD, Deputy Director for Science;
Prof.
Yakutsk
References
1. Butov Yu.S. Dermatovenerology: a guide for doctors / Yu.S. Butov, N.N. Potekaev. – M.: Geotar Media, 2017. – Р. 206-220.
2. Vasilieva L.V. A comparative analysis of the effectiveness of basic methotrexate therapy in combination with chromolaser therapy and methotrexate monotherapy in patients with psoriatic arthritis / L.V. Vasilieva, E.F. Evstratova, A.V. Nikitin // Global science. Development and novelty. Collection of scientific papers, on materials of the international scientific-practical conference. –2016. – P. 19-24.
3. Psoriasis: clinical and epidemiological features and treatment issues / A.L. Bakulev, T.V. Fitileva, E.A. Novoderezhkina [et al.] // Bulletin of Dermatology and Venereology. – 2018. – V. 94, № 3. – Р. 67-76. DOI.org/10.25208/0042-4609-2018-94-3-67-76.
4. Psoriatic arthritis. Clinical recommendations for diagnosis and treatment / T.V. Korotaeva, Y.L. Korsakova, E.Yu. Loginova [et al.]. // Modern Rheumatology Journal. – 2018. – V. 12, № 2. – Р. 22–35. DOI: 10/14412/1996-7012-2018-2-22-35.
5. Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research / D. Van der Heijde, D.D. Gladman, A. Kavanaugh, P.J. Mease // Arthritis Res Ther. – 2020. – V.22, № 1. – Р. 18. doi: 10.1186/s13075-020-2103-8
6. Classification criteria for psoriatic arthritis: development of new criteria from a large international study / W. Taylor, D. Gladman, P. Helliwell [et al.] // Arthritis Rheum. – 2006. – V. 54, № 8. – Р. 2665–2673. DOI:10.1002/art.21972.
7. Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis / M. Souto-Carneiro, L. Tóth, R. Behnisch [et al.] //Ann Rheum Dis. – 2020. – pii: annrheumdis-2019-216374. DOI: 10.1136/annrheumdis-2019-216374.
8. Ma J. The association between biologic agents and the risk of cardiovascular events in patients with psoriasis and psoriatic arthritis: a protocol for a systematic review and meta-analysis / J. Ma, N. Liang, J. Chen, Y. Bai. // Medicine (Baltimore). – 2019. – V.98, № 47. – e18063. DOI: 10.1097/MD.0000000000018063.
9. Ritchlin C.T. Psoriatic arthritis / C.T. Ritchlin, R.A. Colbert, D.D. Gladman // N. Engl. J. Med. – 2017. – V. 376, № 10. – Р. 2095–2096. DOI: 10.1056/NEJMra1505557.
Review
For citations:
Popova K.E., Popova T.E. Psoriatic arthritis: clinical observation. Yakut Medical Journal. 2020;(2):106-108. https://doi.org/10.25789/YMJ.2020.70.32